Clarity in cell line development

Solentim Turns 10: Celebrating a decade of progress and pioneering advances

Solentim is delighted to celebrate its 10-year anniversary today. Despite the uncertain times we currently live in, Solentim continues to forge ahead, and today celebrates another successful year, and a decade of growth and progress. For all of this success we thank our staff, past and present, and all our customers Global operation Over the …

Read more Solentim Turns 10: Celebrating a decade of progress and pioneering advances

Solentim appoints new sales manager for USA East

Solentim is pleased to announce the appointment of Jake Isaacs to the role of Sales Manager, USA East Coast. Jake is based in the Greater Boston area and holds a PhD in biochemistry/biophysics with postdoctoral training in immunology, cell biology and molecular diagnostics. He has a passion for cutting-edge technology and its application to outstanding …

Read more Solentim appoints new sales manager for USA East

Solentim and ATUM to bundle Leap-In Transposase® with the VIPS™ single cell cloning instrument for cell line development

Bournemouth, UK and Newark, CA, USA, 20th April 2020 / Solentim, a global leader in cell line development (CLD) instrumentation, and bioengineering company ATUM, today announced that Solentim will bundle access to the Leap-In Transposase® platform together with the Solentim VIPS™ single cell cloning instrument. Leap-In Transposases enable stable high titer clones to be isolated whilst screening …

Read more Solentim and ATUM to bundle Leap-In Transposase® with the VIPS™ single cell cloning instrument for cell line development

Translate »